Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sherard, E. S.
Right arrow Articles by Couri, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sherard, E. S., Jr.
Right arrow Articles by Couri, D.
NEUROLOGY 1980;30:31
© 1980 American Academy of Neurology

Treatment of childhood epilepsy with valproic acid

Results of the first 100 patients in a 6-month trial

Earl S. Sherard, Jr., M. D., Gerald S. Steiman, M. D. and Daniel Couri, Ph.D.

Department of Pediatrics and Pharmacology, College of Medicine, Ohio State University, and the Division of Pediatric Neurology, Columbus Children's Hospital, Columbus, OH.

we evaluated valproic acid (VPA) for 6 months as therapy for uncontrolled seizures in 100 children, 38 with partial and 62 with generalized epilepsy. Sixty-one patients experienced more than a 75% decrease in seizures. The improvement in generalized epilepsy paralleled adult VPA studies, but partial epilepsy improved more than expected, even though acceptable seizure control was often achieved only after 6 months of VPA therapy. The most significant side effect was gastrointestinal distress, which was alleviated by dietary changes. Limited experience suggested that enteric-coated capsules eliminated gastrointestinal symptoms. Hematologic, hepatic, and behavioral sequelae were minimal.

Address correspondence and reprint requests to Dr. Sherard, 700 Children's Drive, Columbus, OH 43205.

Accepted for publication June 12, 1979.




This article has been cited by other articles:


Home page
J Child NeurolHome page
T. A. Glauser
Behavioral and Psychiatric Adverse Events Associated With Antiepileptic Drugs Commonly Used in Pediatric Patients
J Child Neurol, August 1, 2004; 19(1_suppl): S25 - S38.
[Abstract] [PDF]


Home page
J Child NeurolHome page
T. A. Glauser
Behavioral and Psychiatric Adverse Events Associated With Antiepileptic Drugs Commonly Used in Pediatric Patients
J Child Neurol, January 1, 2004; 19(1_suppl): S25 - S38.
[Abstract] [PDF]


Home page
J Child NeurolHome page
V. Biton, P. Levisohn, S. Hoyler, A. Vuong, and A. E. Hammer
Lamotrigine Versus Valproate Monotherapy--Associated Weight Change in Adolescents With Epilepsy: Results From a Post Hoc Analysis of a Randomized, Double-Blind Clinical Trial
J Child Neurol, February 1, 2003; 18(2): 133 - 139.
[Abstract] [PDF]


Home page
J Child NeurolHome page
D. L. Hurst
The Rapid Change to Monotherapy With Valproic Acid in Children
J Child Neurol, October 1, 1993; 8(4): 357 - 359.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1980 by AAN Enterprises, Inc.